MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 229 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,910 | -13.8% | 11,891 | +7.2% | 0.00% | – |
| Q2 2023 | $137,899 | -16.2% | 11,094 | -5.5% | 0.00% | – |
| Q1 2023 | $164,519 | -17.6% | 11,743 | -15.8% | 0.00% | – |
| Q4 2022 | $199,610 | -85.6% | 13,949 | -74.2% | 0.00% | -100.0% |
| Q3 2022 | $1,382,000 | -92.4% | 54,141 | -91.6% | 0.00% | -92.3% |
| Q2 2022 | $18,220,000 | +3.0% | 641,349 | +27.8% | 0.01% | +18.2% |
| Q1 2022 | $17,695,000 | -26.0% | 501,682 | -12.1% | 0.01% | -21.4% |
| Q4 2021 | $23,913,000 | -20.8% | 570,707 | -7.3% | 0.01% | -30.0% |
| Q3 2021 | $30,201,000 | +46.8% | 615,341 | +24.8% | 0.02% | +53.8% |
| Q2 2021 | $20,571,000 | +8579.7% | 492,932 | +7304.7% | 0.01% | – |
| Q1 2021 | $237,000 | – | 6,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |